These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 20340137)

  • 41. Parkinson's disease genetic mutations increase cell susceptibility to stress: mutant alpha-synuclein enhances H2O2- and Sin-1-induced cell death.
    Jiang H; Wu YC; Nakamura M; Liang Y; Tanaka Y; Holmes S; Dawson VL; Dawson TM; Ross CA; Smith WW
    Neurobiol Aging; 2007 Nov; 28(11):1709-17. PubMed ID: 16978743
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Alpha-synuclein nitration and autophagy response are induced in peripheral blood cells from patients with Parkinson disease.
    Prigione A; Piazza F; Brighina L; Begni B; Galbussera A; Difrancesco JC; Andreoni S; Piolti R; Ferrarese C
    Neurosci Lett; 2010 Jun; 477(1):6-10. PubMed ID: 20399833
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Frequency of the IVS4+66A-G polymorphism in the alpha-synuclein gene in patients with Parkinson's disease in north-western Mexico].
    Ramírez-Jirano LJ; Ruiz-Sandoval JL; Jiménez-Gil FJ; Ramírez-Vega J; Vargas-Frutos E; Gallegos-Arreola MP
    Rev Neurol; 2007 Jan 1-15; 44(1):15-7. PubMed ID: 17199224
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Silencing of human alpha-synuclein in vitro and in rat brain using lentiviral-mediated RNAi.
    Sapru MK; Yates JW; Hogan S; Jiang L; Halter J; Bohn MC
    Exp Neurol; 2006 Apr; 198(2):382-90. PubMed ID: 16455076
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A survey of genetic and epigenetic variation affecting human gene expression.
    Pastinen T; Sladek R; Gurd S; Sammak A; Ge B; Lepage P; Lavergne K; Villeneuve A; Gaudin T; Brändström H; Beck A; Verner A; Kingsley J; Harmsen E; Labuda D; Morgan K; Vohl MC; Naumova AK; Sinnett D; Hudson TJ
    Physiol Genomics; 2004 Jan; 16(2):184-93. PubMed ID: 14583597
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson disease.
    Maraganore DM; de Andrade M; Elbaz A; Farrer MJ; Ioannidis JP; Krüger R; Rocca WA; Schneider NK; Lesnick TG; Lincoln SJ; Hulihan MM; Aasly JO; Ashizawa T; Chartier-Harlin MC; Checkoway H; Ferrarese C; Hadjigeorgiou G; Hattori N; Kawakami H; Lambert JC; Lynch T; Mellick GD; Papapetropoulos S; Parsian A; Quattrone A; Riess O; Tan EK; Van Broeckhoven C;
    JAMA; 2006 Aug; 296(6):661-70. PubMed ID: 16896109
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Neurodegeneration and epigenetics].
    Iwata A
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2012 Nov; 32(5-6):269-73. PubMed ID: 23373314
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Deregulation of α-synuclein in Parkinson's disease: Insight from epigenetic structure and transcriptional regulation of SNCA.
    Guhathakurta S; Bok E; Evangelista BA; Kim YS
    Prog Neurobiol; 2017 Jul; 154():21-36. PubMed ID: 28445713
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Unraveling the Complex Interplay between Alpha-Synuclein and Epigenetic Modification.
    Sugeno N; Hasegawa T
    Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047616
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Generation of gene-corrected iPSC line from Parkinson's disease patient iPSC line with alpha-SNCA A53T mutation.
    Lee SY; Jeong S; Kim J; Chung SK
    Stem Cell Res; 2018 Jul; 30():145-149. PubMed ID: 29906669
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hypomethylation of intron1 of α-synuclein gene does not correlate with Parkinson's disease.
    Guhathakurta S; Evangelista BA; Ghosh S; Basu S; Kim YS
    Mol Brain; 2017 Feb; 10(1):6. PubMed ID: 28173842
    [TBL] [Abstract][Full Text] [Related]  

  • 52. SNCA variant associated with Parkinson disease and plasma alpha-synuclein level.
    Mata IF; Shi M; Agarwal P; Chung KA; Edwards KL; Factor SA; Galasko DR; Ginghina C; Griffith A; Higgins DS; Kay DM; Kim H; Leverenz JB; Quinn JF; Roberts JW; Samii A; Snapinn KW; Tsuang DW; Yearout D; Zhang J; Payami H; Zabetian CP
    Arch Neurol; 2010 Nov; 67(11):1350-6. PubMed ID: 21060011
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Parkinson's disease correlates with promoter methylation in the α-synuclein gene.
    Pihlstrøm L; Berge V; Rengmark A; Toft M
    Mov Disord; 2015 Apr; 30(4):577-80. PubMed ID: 25545759
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Molecular analysis of α-synuclein gene in Parkinson's disease in North Karnataka, India.
    Kadakol GS; Kulkarni SS; Wali GM; Gai PB
    Neurol India; 2014; 62(2):149-52. PubMed ID: 24823723
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Epigenetic upregulation of alpha-synuclein in the rats exposed to methamphetamine.
    Jiang W; Li J; Zhang Z; Wang H; Wang Z
    Eur J Pharmacol; 2014 Dec; 745():243-8. PubMed ID: 25445041
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Epigenetic approach to early-onset Parkinson's disease: low methylation status of SNCA and PARK2 promoter regions.
    Eryilmaz IE; Cecener G; Erer S; Egeli U; Tunca B; Zarifoglu M; Elibol B; Bora Tokcaer A; Saka E; Demirkiran M; Akbostanci C; Dogu O; Colakoglu B; Kenangil G; Kaleagasi H
    Neurol Res; 2017 Nov; 39(11):965-972. PubMed ID: 28830306
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The alpha-synuclein gene and Parkinson disease in a Chinese population.
    Chan DK; Mellick G; Cai H; Wang XL; Ng PW; Pang CP; Woo J; Kay R
    Arch Neurol; 2000 Apr; 57(4):501-3. PubMed ID: 10768624
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Alpha-synuclein and heroin craving in opiate-dependent patients on injectable heroin maintenance.
    Dürsteler-MacFarland KM; Brugger I; Bönsch D; Schmid O; Kornhuber J; Bleich S; Wiesbeck GA
    Addict Biol; 2012 Sep; 17(5):875-86. PubMed ID: 21309955
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Alpha-synuclein p.H50Q, a novel pathogenic mutation for Parkinson's disease.
    Appel-Cresswell S; Vilarino-Guell C; Encarnacion M; Sherman H; Yu I; Shah B; Weir D; Thompson C; Szu-Tu C; Trinh J; Aasly JO; Rajput A; Rajput AH; Jon Stoessl A; Farrer MJ
    Mov Disord; 2013 Jun; 28(6):811-3. PubMed ID: 23457019
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Methylation regulates alpha-synuclein expression and is decreased in Parkinson's disease patients' brains.
    Jowaed A; Schmitt I; Kaut O; Wüllner U
    J Neurosci; 2010 May; 30(18):6355-9. PubMed ID: 20445061
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.